Inflammatory Microenvironment of Acute Myocardial Infarction Prevents Regeneration of Heart with Stem Cells Therapy.


Journal

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
ISSN: 1421-9778
Titre abrégé: Cell Physiol Biochem
Pays: Germany
ID NLM: 9113221

Informations de publication

Date de publication:
2019
Historique:
accepted: 19 11 2019
entrez: 22 11 2019
pubmed: 22 11 2019
medline: 28 11 2019
Statut: ppublish

Résumé

Over the past years, the benefits of stem cell therapy approach for treatment of the cardiovascular diseases have been shown through the rebuilding of new cardiomyocytes and blood vessels. while a successful regeneration of the myocardium has been proven on the animal models of acute myocardial injuries resulted from the stem cells transplantation, no significant long-term regenerative with autologous stem cell therapy in patients with acute myocardial infarction have been reported based on recent meta-analyses. It seems that the inflammatory microenvironment of acute myocardial infarction has an inhibitory effect on the stem cells potential for regenerating the injured myocardium. Secretion of critical cytokines with pro-inflammatory properties including tumor necrosis factor-α, interleukin-1β, and interleukin-6 as well as induction of hypoxic condition and finally formation of cytotoxic elements cause the cellular death and hinder the stem cells proliferation and differentiation. Based on the evidence, application of some approaches like co-delivery of mesenchymal stem cells with the other useful cells, using the stem cells derived productions, administration of preconditioned and modified cells, and also using the anti-inflammatory agents besides the cell therapy are hypothesized as the primary developed safe and practical approaches for decreasing destructive effects of the inflammation on the implanted stem/progenitor cells. In this review, we critically discuss the quiddity of the inflammatory microenvironment and its promoted mechanisms as the main elements to hinder the efficacy of stem cell therapy in the cases of acute myocardial infarction. Also, we finally propose some applied solutions to the problem of cardiac regeneration with stem cells therapy.

Identifiants

pubmed: 31749350
doi: 10.33594/000000180
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

887-909

Informations de copyright

© Copyright by the Author(s). Published by Cell Physiol Biochem Press.

Déclaration de conflit d'intérêts

The authors declare they have no conflict of interest.

Auteurs

Saeed Khodayari (S)

Cancer Research Center, Tehran University of Medical Sciences, Tehran, Iran.
International Stem Cell Academy, Cologne/Düsseldorf, Germany.
International Center for Personalized Medicine, Düsseldorf, Germany.

Hamid Khodayari (H)

Cancer Research Center, Tehran University of Medical Sciences, Tehran, Iran.
International Stem Cell Academy, Cologne/Düsseldorf, Germany.
International Center for Personalized Medicine, Düsseldorf, Germany.

Ali Zahedi Amiri (AZ)

Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada.
Manitoba Centre for Proteomics and Systems Biology, Winnipeg, MB, Canada.

Maryam Eslami (M)

Applied Biotechnology Research Center, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran.

Dariush Farhud (D)

Farhud-Nayernia Group for Genomics Medicine, Farhud Clinic for Medical Genetics, Tehran, Iran.
School of Public Health, Tehran University of Medical Science, Tehran, Iran.

Jürgen Hescheler (J)

International Stem Cell Academy, Cologne/Düsseldorf, Germany.
Institute of Neurophysiology, University of Cologne, Cologne, Germany.

Karim Nayernia (K)

International Stem Cell Academy, Cologne/Düsseldorf, Germany, nayernia@p7medicine.com.
International Center for Personalized Medicine, Düsseldorf, Germany.
Farhud-Nayernia Group for Genomics Medicine, Farhud Clinic for Medical Genetics, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH